User profiles for Andrea Arighi

Andrea Arighi

Neurologist
Verified email at policlinico.mi.it
Cited by 3874

[HTML][HTML] Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study …

…, A Padovani, D Galimberti, E Scarpini, A Arighi… - The Lancet …, 2015 - thelancet.com
Background Frontotemporal dementia is a highly heritable neurodegenerative disorder. In
about a third of patients, the disease is caused by autosomal dominant genetic mutations …

[HTML][HTML] Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

…, S Fostinelli, HH Chiang, A Alberici, A Arighi… - The Lancet …, 2020 - thelancet.com
Background Frontotemporal dementia is a heterogenous neurodegenerative disorder, with
about a third of cases being genetic. Most of this genetic component is accounted for by …

Circulating miRNAs as potential biomarkers in Alzheimer's disease

…, L Ghezzi, SMG Cioffi, A Arighi… - Journal of …, 2014 - content.iospress.com
Several micro (mi) RNA are deregulated in brain, cerebrospinal fluid (CSF), and serum/plasma
from patients with Alzheimer's disease (AD). The aim of the study was to profile …

[HTML][HTML] Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study

…, JD Rohrer, C Andersson, S Archetti, A Arighi… - Neurobiology of …, 2018 - Elsevier
Frontotemporal dementia (FTD) is a highly heritable condition with multiple genetic causes.
In this study, similarities and differences of gray matter (GM) atrophy patterns were assessed …

Spontaneous ARIA-like events in cerebral amyloid angiopathy–related inflammation: a multicenter prospective longitudinal cohort study

…, JC DiFrancesco, M Zedde, G Basso, A Arighi… - Neurology, 2021 - AAN Enterprises
Background and Objectives The goal of this work was to investigate the natural history and
outcomes after treatment for spontaneous amyloid-related imaging abnormalities (ARIA)-like …

Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study

…, C Andersson, V Jelic, H Thonberg, A Arighi… - The Lancet …, 2019 - thelancet.com
Background Neurofilament light chain (NfL) is a promising blood biomarker in genetic
frontotemporal dementia, with elevated concentrations in symptomatic carriers of mutations in GRN…

Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation

…, C Fenoglio, M Serpente, C Villa, R Bonsi, A Arighi… - Biological …, 2013 - Elsevier
Background A hexanucleotide repeat expansion in the first intron of C9ORF72 has been
shown to be responsible for a high number of familial cases of amyotrophic lateral sclerosis or …

[HTML][HTML] Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms

…, M Marano, A Magliozzi, A Di Fonzo, A Arighi… - Neurobiology of …, 2023 - Elsevier
The early differential diagnosis of Parkinson's disease (PD) and atypical Parkinsonian
syndromes (APS), including corticobasal degeneration (CBD) and progressive supranuclear …

[HTML][HTML] The role of glymphatic system in Alzheimer's and Parkinson's disease pathogenesis

FR Buccellato, M D'Anca, M Serpente, A Arighi… - Biomedicines, 2022 - mdpi.com
Alzheimer’s disease (AD) is the most common cause of neurodegenerative dementia, whilst
Parkinson’s disease (PD) is a neurodegenerative movement disorder. These two …

[HTML][HTML] MiRNA profiling in plasma neural-derived small extracellular vesicles from patients with Alzheimer's disease

…, M Arcaro, F Sorrentino, C Visconte, A Arighi… - Cells, 2020 - mdpi.com
Small extracellular vesicles (EVs) are able to pass from the central nervous system (CNS)
into peripheral blood and contain molecule markers of their parental origin. The aim of our …